Now showing items 1-1 of 1

    • Gellona V., José; Zarraonandia A., Antón; Zúñiga D., Alvaro; Palma C., Renato; Contreras P., Jaime; Silva Ch., Jaime; González D., Róbinson; Quintana V., Carlos (2006)
      Background: Tumor necrosis factor alpha, interleukin 6 and 1 have a pathogenic role in Crohn’s disease. Infliximab, a monoclonal antibody against tumor necrosis factor, is useful in the treatment of Crohn’s disease, ...